Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fulgent Genetics Inc
(NQ:
FLGT
)
22.56
-0.56 (-2.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Fulgent Genetics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
AMC Goes Parabolic: Looking For The Next Short Squeeze Candidate.
June 04, 2021
Moviegoers at an AMC theater waiting for a showing of the last Fast & Furious movie (photo via author). Crypto Crabs While AMC Skyrockets A point we made last week...
Via
Benzinga
AMC Goes Parabolic
June 03, 2021
Our top name from April was up 568% as of Wednesday's close. Looking for the next short squeeze candidate.
Via
Talk Markets
8 Stocks With The Highest Short Percent Of Float Right Now
June 02, 2021
Traders often look at short interest to get a sense of how many people are bearish on a stock and how strong the possibility of a short squeeze is. But simply looking at the size...
Via
Benzinga
Step Aside AMC: Here Are The Most Shorted Stocks Right Now
June 02, 2021
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more...
Via
Talk Markets
How Long Will Fulgent Genetics Benefit From the Pandemic?
May 29, 2021
Genetic testing for the coronavirus is slowing.
Via
The Motley Fool
Exposures
COVID-19
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
Forget Dogecoin -- Buy These 3 Growth Stocks Instead
May 18, 2021
They are all coming off some impressive quarterly results.
Via
The Motley Fool
A Look Into Healthcare Sector Value Stocks
May 17, 2021
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Week In Review: GenScript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse
May 15, 2021
GenScript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to GenScript's Legend Biotech CAR-T subsidiary. Before the...
Via
Talk Markets
What Are Investors Thinking About Fulgent Genetics?
May 14, 2021
Hint: It has something to do with COVID-19.
Via
The Motley Fool
Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech
May 10, 2021
From
Fulgent Genetics, Inc.
Via
Business Wire
Why Investors Loved Fulgent Genetics' Q1 Results
May 07, 2021
More than 4,500% revenue growth gave Wall Street and shareholders something to cheer about.
Via
The Motley Fool
Fulgent Genetics, Inc. Common Stock (FLGT) Q1 2021 Earnings Call Transcript
May 07, 2021
FLGT earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's After-Market Session
May 06, 2021
Gainers T2 Biosystems (NASDAQ:TTOO) share...
Via
Benzinga
Fulgent Genetics Reports Record First Quarter Financial Results
May 06, 2021
From
Fulgent Genetics, Inc.
Via
Business Wire
Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer
May 06, 2021
From
Fulgent Genetics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Why Shares of Fulgent Genetics Fell 20% in April
May 05, 2021
Good news for the U.S. has been bad news for shareholders.
Via
The Motley Fool
2 Numbers That Explain How This Hypergrowth Company Can Make You Rich
April 27, 2021
The genetic testing giant's journey resembles the path of past winners.
Via
The Motley Fool
3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan
April 24, 2021
The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit.
Via
The Motley Fool
Exposures
COVID-19
2 Unsustainable Growth Stocks to Avoid
April 22, 2021
Be wary of companies posting abnormal growth rates.
Via
The Motley Fool
Fulgent Genetics' CEO Just Told Investors To Look Out For An Acquisition
April 20, 2021
He also gave clues that point to a few possible targets.
Via
The Motley Fool
1 Number That Should Shock Fulgent Genetics Investors
April 17, 2021
Growth last year was awesome, but there is something to be even more excited about.
Via
The Motley Fool
Exposures
COVID-19
Got $5,000? These 2 Ultra-Cheap Stocks Are Bargain Buys
April 13, 2021
They've underperformed the S&P 500 in the past month, but these stocks show lots of potential over the long term.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.